UCSF Artificial Kidney Project Tapped for Accelerated FDA Program

April 9, 2012

An effort led by UCSF bioengineer Shuvo Roy to create an implantable artificial kidney for dialysis patients has been selected as one of the first projects to undergo more timely and collaborative review at the U.S. Food and Drug Administration. Dr. Roy's project is one of three selected from over 30 applications to the FDA's Innovation Pathway 2.0 program, which aims to shorten the time and cost of development, assessment and review of medical devices. For more information, read the FDA press release and the UCSF Today article.